// App-Quantinova.ai

2520 : IRS-1/LC3 nuclear structures and glioblastoma drug resistance

Researchers

Presenter

  • Adam Lassak

Principal Investigators

  • Dorota Wyczechowska

  • Anna Wilk

  • Adriana Zapata

  • Mathew Dean

  • Luis DelValle

  • Jann N. Sarkaria

  • Augusto Ochoas

  • Francesca Peruzzi

  • Krzysztof Reiss

Medical Centers

  • Louisiana State University HSC, New Orleans, LA

  • University of South Alabama, Mitchell Cancer Institute, Mobile, AL

  • Mayo Clinic, Department of Hematology, Rochester, MN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Glioblastoma

  • Solid malignancies

Biomarkers

  • 1A/1B-light chain 3

  • Promyelocytic Leukemia

Drug/Treatment

  • Temozolomide

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved